Journal of Skin and Stem Cell

Published by: Kowsar

Effect of Hydroquinone Plus Neodymium-Doped Yttrium Aluminium Garnet Laser With and Without CO2 Fractional Laser on Resistant Dermal Melasma

Abbas Zamanian 1 , Elham Behrangi 1 , Gholam Hossein Ghafarpour 1 , Golnaz Mehran 1 , Romina Espahbodi 2 , Tanaz Hoseinzade Fakhim 1 , * and Zahra Azizian 1
Authors Information
1 Department of Dermatology, Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
2 Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
Article information
  • Journal of Skin and Stem Cell: June 1, 2015, 2 (2); e30290
  • Published Online: June 23, 2015
  • Article Type: Research Article
  • Received: May 31, 2015
  • Accepted: June 6, 2015
  • DOI: 10.17795/jssc30290

To Cite: Zamanian A, Behrangi E, Ghafarpour G H, Mehran G, Espahbodi R, et al. Effect of Hydroquinone Plus Neodymium-Doped Yttrium Aluminium Garnet Laser With and Without CO2 Fractional Laser on Resistant Dermal Melasma, J Skin Stem Cell. 2015 ; 2(2):e30290. doi: 10.17795/jssc30290.

Abstract
Copyright © 2015, Skin and Stem Cell Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
References
  • 1. Tamega Ade A, Miot LD, Bonfietti C, Gige TC, Marques ME, Miot HA. Clinical patterns and epidemiological characteristics of facial melasma in Brazilian women. J Eur Acad Dermatol Venereol. 2013; 27(2): 151-6[DOI][PubMed]
  • 2. Miot LD, Miot HA, Silva MG, Marques ME. [Physiopathology of melasma]. An Bras Dermatol. 2009; 84(6): 623-35[PubMed]
  • 3. Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol. 2006; 55(6): 1048-65[DOI][PubMed]
  • 4. Cestari T, Arellano I, Hexsel D, Ortonne JP, Latin American Pigmentary Disorders A. Melasma in Latin America: options for therapy and treatment algorithm. J Eur Acad Dermatol Venereol. 2009; 23(7): 760-72[DOI][PubMed]
  • 5. Alsaad SM, Ross EV, Mishra V, Miller L. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser. Lasers Surg Med. 2014; 46(10): 736-40[DOI][PubMed]
  • 6. Wattanakrai P, Mornchan R, Eimpunth S. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. Dermatol Surg. 2010; 36(1): 76-87[DOI][PubMed]
  • 7. Jalaly NY, Valizadeh N, Barikbin B, Yousefi M. Low-power fractional CO(2) laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study. Am J Clin Dermatol. 2014; 15(4): 357-63[DOI][PubMed]
  • 8. Goldberg DJ. Laser Treatment of Pigmented Lesions. Dermatol Clin. 1997; 15(3): 397-407
  • 9. Anderson RR, Margolis RJ, Watenabe S, Flotte T, Hruza GJ, Dover JS. Selective photothermolysis of cutaneous pigmentation by Q-switched Nd: YAG laser pulses at 1064, 532, and 355 nm. J Invest Dermatol. 1989; 93(1): 28-32[PubMed]
  • 10. Nelson JS, Applebaum J. Treatment of Superficial Cutaneous Pigmented Lesions by Melanin-specific Selective Photothermolysis Using the Q-switched Ruby Laser. Ann Plastic Surg. 1992; 29(3): 231-7
  • 11. Goldberg DJ. Benign pigmented lesions of the skin. Treatment with the Q-switched ruby laser. J Dermatol Surg Oncol. 1993; 19(4): 376-9[PubMed]
  • 12. Haddad AL, Matos LF, Brunstein F, Ferreira LM, Silva A, Costa DJ. A clinical, prospective, randomized, double-blind trial comparing skin whitening complex with hydroquinone vs. placebo in the treatment of melasma. Int J Dermatol. 2003; 42(2): 153-6[PubMed]
  • 13. Fabi SG, Friedmann DP, Niwa Massaki AB, Goldman MP. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma. Lasers Surg Med. 2014; 46(7): 531-7[DOI][PubMed]
  • 14. Bansal C, Naik H, Kar HK, Chauhan A. A Comparison of Low-Fluence 1064-nm Q-Switched Nd: YAG Laser with Topical 20% Azelaic Acid Cream and their Combination in Melasma in Indian Patients. J Cutan Aesthet Surg. 2012; 5(4): 266-72[DOI][PubMed]
  • 15. Kim HS, Kim EK, Jung KE, Park YM, Kim HO, Lee JY. A split-face comparison of low-fluence Q-switched Nd: YAG laser plus 1550 nm fractional photothermolysis vs. Q-switched Nd: YAG monotherapy for facial melasma in Asian skin. J Cosmet Laser Ther. 2013; 15(3): 143-9[DOI][PubMed]
  • 16. Grimes PE. Melasma. Arch Dermatol. 1995; 131(12): 1453
  • 17. Hexsel D, Lacerda DA, Cavalcante AS, Machado Filho CA, Kalil CL, Ayres EL, et al. Epidemiology of melasma in Brazilian patients: a multicenter study. Int J Dermatol. 2014; 53(4): 440-4[DOI][PubMed]
  • 18. Bartoli Miot LD, Amante Miot H, Da Silva MG, Marques ME. Physiopathology of melisma. An Bras Dermatol. 2009; 84(6)
  • 19. Grimes PE. Management of Hyperpigmentation in Darker Racial Ethnic Groups. Sem Cutan Med Surg. 2009; 28(2): 77-85[DOI]
  • 20. Arora P, Sarkar R, Garg VK, Arya L. Lasers for treatment of melasma and post-inflammatory hyperpigmentation. J Cutan Aesthet Surg. 2012; 5(2): 93-103[DOI][PubMed]
  • 21. Rathi SK, Achar A. Melasma: A clinico-epidemiological study of 312 cases. Indian J Dermatol. 2011; 56(4): 380-2[DOI]
  • 22. Jeong SY, Shin JB, Yeo UC, Kim WS, Kim IH. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream. Dermatol Surg. 2010; 36(6): 909-18[DOI][PubMed]
  • 23. Chan NP, Ho SG, Shek SY, Yeung CK, Chan HH. A case series of facial depigmentation associated with low fluence Q-switched 1,064 nm Nd:YAG laser for skin rejuvenation and melasma. Lasers Surg Med. 2010; 42(8): 712-9[DOI][PubMed]
  • 24. Polnikorn N. Treatment of refractory dermal melasma with the MedLite C6 Q-switched Nd:YAG laser: two case reports. J Cosmet Laser Ther. 2008; 10(3): 167-73[DOI][PubMed]
  • 25. Berlin AL, Dudelzak J, Hussain M, Phelps R, Goldberg DJ. Evaluation of clinical, microscopic, and ultrastructural changes after treatment with a novel Q-switched Nd:YAG laser. J Cosmet Laser Ther. 2008; 10(2): 76-9[DOI][PubMed]
  • 26. Kim MJ, Kim JS, Cho SB. Punctate leucoderma after melasma treatment using 1064-nm Q-switched Nd:YAG laser with low pulse energy. J Eur Acad Dermatol Venereol. 2009; 23(8): 960-2[DOI][PubMed]
  • 27. Manaloto RMP, Alster T. Erbium:YAG Laser Resurfacing for Refractory Melasma. Dermatol Surg. 1999; 25(2): 121-3
  • 28. Palumbo A, D'Ischia M, Misuraca G, Prota G. Mechanism of inhibition of melanogenesis by hydroquinone. Biochimica et Biophysica Acta (BBA) - General Subjects. 1991; 1073(1): 85-90[DOI]
  • 29. Amer M, Metwalli M. Topical hydroquinone in the treatment of some hyperpigmentary disorders. Int J Dermatol. 1998; 37(6): 449-50[PubMed]
  • 30. Vachiramon V, Sirithanabadeekul P, Sahawatwong S. Low-fluence Q-switched Nd: YAG 1064-nm laser and intense pulsed light for the treatment of melasma. J Eur Acad Dermatol Venereol. 2015; 29(7): 1339-46[DOI][PubMed]
  • 31. Ball Arefiev KL, Hantash BM. Advances in the treatment of melasma: a review of the recent literature. Dermatol Surg. 2012; 38(7 Pt 1): 971-84[DOI][PubMed]
  • 32. Choi CP, Yim SM, Seo SH, Ahn HH, Kye YC, Choi JE. Retrospective analysis of melasma treatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser vs. low-fluence Q-switched Nd:YAG laser monotherapy. J Cosmet Laser Ther. 2015; 17(1): 2-8[DOI][PubMed]
  • 33. Park KY, Kim DH, Kim HK, Li K, Seo SJ, Hong CK. A randomized, observer-blinded, comparison of combined 1064-nm Q-switched neodymium-doped yttrium-aluminium-garnet laser plus 30% glycolic acid peel vs. laser monotherapy to treat melasma. Clin Expe Dermatol. 2011; 36(8): 864-70[DOI]
  • 34. Lee DB, Suh HS, Choi YS. A comparative study of low-fluence 1,064 nm Q-Switched Nd:YAG laser with or without chemical peeling using Jessner's solution in melasma patients. J Cosmet Laser Ther. 2014; 16(6): 264-70[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments